Total Addressable Market (TAM) – 530 million adults globally at risk of diabetes
Serviceable Addressable Market (SAM) – 96 million adults in the U.S. with prediabetes
Serviceable Obtainable Market (SOM) – Targeting 0.5% of the U.S. market initially – Approximately 480,000 individuals
Competitor Overview
Direct Competitors: – No direct competitors currently targeting prediabetes monitoring.
Indirect Competitors: Dexcom & Abbott: – Focus on glucose monitoring for type 2 diabetes patients. – Invasive methods requiring blood samples. Traditional Diagnostic Labs: – Fasting, blood draws, and clinic visits required.
Financial Picture
We aim to raise $75,000 over the next 12 months through a diversified funding strategy. This includes grants, owner contributions, and investor funding to support R&D, prototyping, and commercialization milestones